Vaxcyte Inc. logo

Vaxcyte Inc.

PCVX | NASDAQ
Chart Builder DCF Calculator
$58.92
+$0.79 (+1.36%)
At close: Sep 21, 2026, 4:00 PM ET
$58.11
-$0.81 (-1.37%)
Pre-market: Sep 22, 2026, 4:01 AM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-766.63M -463.93M -402.27M -223.49M -100.08M -89.22M
Depreciation & Amortization
24.86M 15.85M 10.17M 9.45M 3.46M 1.41M
Stock-Based Compensation
138.85M 84.82M 48.76M 23.65M 10.73M 5.43M
Other Working Capital
-23.36M -89.48M 70.1M 9.84M -24.54M 9.17M
Other Non-Cash Items
-49.2M -34.47M -34.78M 7.05M 1.5M 179K
Deferred Income Tax
n/a n/a n/a n/a n/a 301K
Change in Working Capital
-3.45M -54.9M 81.32M 12.74M -37.01M 35.27M
Operating Cash Flow
-655.58M -452.63M -296.79M -170.6M -121.39M -46.63M
Capital Expenditures
-13.71M -22.43M -67.88M -5.84M -6.56M -1.16M
Cash Acquisitions
n/a n/a n/a n/a n/a 50K
Purchase of Investments
-1.21B -3.09B -1.33B -102.75M -336.34M n/a
Sales Maturities Of Investments
1.71B 1.2B 624.46M 183.17M 130.56M n/a
Other Investing Acitivies
-43.26M -96.73M n/a n/a 26K n/a
Investing Cash Flow
437.35M -2.01B -773.31M 74.59M -212.31M -1.11M
Debt Repayment
n/a n/a n/a n/a n/a -61K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-10.99M 12.85M 3.77M 5.07M 3.9M 1.05M
Financial Cash Flow
2.01M 2.45B 639.81M 861.55M 17.8M 374.87M
Net Cash Flow
-213.77M -9.36M -436.97M 765.67M -316.34M 327.22M
Free Cash Flow
-669.29M -475.05M -364.67M -176.44M -127.95M -47.78M
Adj. Free Cash Flow
-808.14M -559.88M -413.43M -200.09M -138.68M -53.22M
Maintenance CapEx
-13.71M -15.85M -10.17M -5.84M -3.46M -1.16M
Growth CapEx
n/a -6.58M -57.71M n/a -3.1M n/a
Owner Earnings
-669.29M -468.47M -306.96M -176.44M -124.85M -47.78M

© 2026 bestshares.com. All rights reserved.